Guardant Health, Inc. (GH)
NASDAQ: GH · IEX Real-Time Price · USD
-0.56 (-1.84%)
At close: Jun 18, 2024, 4:00 PM
+1.06 (3.54%)
After-hours: Jun 18, 2024, 4:52 PM EDT

Guardant Health Revenue

Guardant Health had revenue of $603.73M in the twelve months ending March 31, 2024, with 25.21% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $168.49M with 30.90% year-over-year growth. In the year 2023, Guardant Health had annual revenue of $563.95M with 25.45% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
3.66B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023563.95M114.41M25.45%
Dec 31, 2022449.54M75.89M20.31%
Dec 31, 2021373.65M86.92M30.32%
Dec 31, 2020286.73M72.36M33.75%
Dec 31, 2019214.38M123.74M136.52%
Dec 31, 201890.64M40.80M81.85%
Dec 31, 201749.84M24.59M97.40%
Dec 31, 201625.25M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 6.54B
Perrigo Company 4.56B
Integer Holdings 1.63B
Neogen 929.24M
Waystar Holding 747.13M
Axsome Therapeutics 251.02M
Merus 38.34M
Avidity Biosciences 10.87M
Revenue Rankings